Sage Journals: Discover world-class research

Abstract

Objective

Non-surgical treatment can be effective for many musculoskeletal conditions. Improving access to these options may improve the efficiency of hospitals. The Orthopaedic Physiotherapy Screening Clinic and Multidisciplinary Service offers early comprehensive assessment and coordinated, patient-centred care within a multidisciplinary framework. Our aim was to assess its cost-effectiveness compared with usual orthopaedic care.

Methods

A Markov model was constructed to estimate the quality-adjusted life years and health care costs from the perspective of health care payers for outpatients with low back, knee or shoulder conditions compared to usual orthopaedic care. Data were obtained from a retrospective chart review, administrative sources, literature and expert opinion. The time frame was five years and all costs were reported in 2011 $AUD.

Results

Compared with usual orthopaedic care, the physiotherapist-led service costs an additional $495 per Quality Adjusted Life Year gained. The model remained cost-effective over a range of one-way sensitivity analyses.

Conclusion

The physiotherapist-led service is likely to be highly cost-effective. Determining the optimal mix of hospital orthopaedic outpatient services may require more advanced modeling techniques to be applied.

Keywords

cost-effectiveness economic evaluation orthopaedics physiotherapy

Get full access to this article

View all access options for this article.

References

Australian Institute of Health and Welfare. Health expenditure for arthritis and musculoskeletal conditions. 2004–05. Canberra: AIHW, 2009.

Australian Orthopaedic Association National Joint Replacement Registry. Annual Report 2013. In: Hip and Knee Arthroplasty. Adelaide: University of Adelaide, 2013.

Bozic

. Use of cost-effectiveness analysis to evaluate new technologies in orthopaedics. The case of alternative bearing surfaces in total hip arthroplasty. J Bone Joint Surg 2006; 88: 706–714.

Brauer

Neumann

Rosen

. Trends in cost effectiveness analyses in orthopaedic surgery. Clin Orthopaed Related Res 2007; 457: 42–48.

Brauer

. Cost-utility analyses in orthopaedic surgery. J Bone Joint Surg 2005; 87: 1253–1259.

Rymaszewski

. A team approach to musculo-skeletal disorders. Ann R Coll Surg Engl 2005; 87: 174–80.

National Health Priority Action Council (NHPAC). National Chronic Disease Strategy. Australian Government Department of Health and Ageing, Editor, Canberra, 2006.

Queensland Health. Queensland strategy for chronic disease 2005-2015. Queensland Government, Editor, Brisbane, 2005.

Smith

Raymer

. Orthopaedic physiotherapy screening clinics - an approach to managing overburdened orthopaedic services (Abstract). Physiotherapy 2007; 93: S746–S746.

10.

Durrell

. Expanding the scope of physiotherapy: clinical physiotherapy specialists in consultants' clinics. Man Ther 1996; 1: 210–213.

11.

Hattam

Smeatham

. Evaluation of an orthopaedic screening service in primary care. Clin Performance Qual Health Care 1999; 7: 121–124.

12.

Hockin

Bannister

. The extended role of a physiotherapist in an outpatient orthopaedic clinic. Physiotherapy 1994; 80: 281–284.

13.

Oldmeadow

. Experienced physiotherapists as gatekeepers to hospital orthopaedic outpatient care. Med J Aust 2007; 186: 625–628.

14.

Schoch

Adair . Successfully reforming orthopaedic outpatients. Aust Health Rev 2012; 36: 233–237.

15.

Blackburn

. Physiotherapy-led triage clinic for low back pain. Aust Health Rev 2009; 33: 663–670.

16.

Rigge

. Quality of life of long wait orthopaedic patients before and after admission: a consumer audit. Qual Health Care 1994; 3: 159–163.

17.

Williams

. The burden of waiting for hip and knee replacements in Ontario. Ontario Hip and Knee Replacement Project Team. J Eval Clin Pract 1997; 3: 59–68.

18.

Ackerman

. Severely compromised quality of life in women and those of lower socioeconomic status waiting for joint replacement surgery. Arthritis Rheum 2005; 53: 653–658.

19.

Fortin

. Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee. Arthritis Rheum 2002; 46: 3327–3330.

20.

Hajat

. Does waiting for total hip replacement matter? Prospective cohort study. J Health Serv Res Policy 2002; 7: 19–25.

21.

Mahon

. Health-related quality of life and mobility of patients awaiting elective total hip arthroplasty: a prospective study. CMAJ 2002; 167: 1115–1121.

22.

Hertzman

Johnsson

Lindgren

. Cost of sick leave for total hip replacement. Acta Orthop Scand 1988; 59: 266–269.

23.

Johnsson

Persson

. Occupation after hip replacement for arthrosis. Acta Orthop Scand 1986; 57: 197–200.

24.

Rossvoll

. Incapacity for work in elective orthopaedic surgery: a study of occurrence and the probability of returning to work after treatment. J Epidemiol Commun Health 1993; 47: 388–394.

25.

Brown

. The OMENS trial: opportunistic evaluation of musculo-skeletal physician care among orthopaedic outpatients unlikely to require surgery. Health Bull 2001; 59: 198–210.

26.

Daker-White

. A randomised controlled trial. Shifting boundaries of doctors and physiotherapists in orthopaedic outpatient departments. J Epidemiol Commun Health 1999; 53: 643–650.

27.

Smith

Gravelle

. The practice of discounting in economic evaluations of healthcare interventions. Int J Technol Assess Health Care 2001; 17: 236–243.

28.

Queensland Health. Our performance, http://www.health.qld.gov.au/performance/default.asp (2013, accessed 12 April 2013).

29.

Queensland Health. Hospital Performance Statewide for Specialist Outpatients (Orthopaedics), (2013, accessed 12 April 2013) http://www.health.qld.gov.au/hospitalperformance/op-main.aspx?hospital=99999.

30.

Hawthorne

Richardson

Osborne

. The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life. Qual Life Res 1999; 8: 209–224.

31.

Richardson J and Iezzi A. Psychometric validity and the AQoL-8D multi attribute utility instrument in research paper 2011 (71). Melbourne: Centre for Health Economics Monash University, 2011.

32.

Henry

Hill

Harris

. Drug prices and value for money: the Australian Pharmaceutical Benefits Scheme. JAMA 2005; 294: 2630–2632.

33.

Shiroiwa

. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ 2010; 19: 422–437.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.03 MB

0.09 MB

Cost-effectiveness of a physiotherapist-led service for orthopaedic outpatients